Global Gene Synthesis Software Market, By Application (Research and Development Activities, Diagnostics, Therapeutics, Others) End User (Academic and Research Institutes, Biotech and Pharmaceutical Companies, Diagnostic Laboratories, Others), Synthesis Type (Gene Library Synthesis, Custom Gene Synthesis), Method (Solid Phase Synthesis, Chip-Based DNA Synthesis, PCR-Based Enzyme Synthesis), End User (Hospital and Clinics, Diagnostic Laboratories, Others) – Industry Trends and Forecast to 2030.
Gene Synthesis Software Market Analysis and Size
It has been witnessed that supportive government policies related with synthetic biology are the major driving factors of the market. Scientific communities are discovering untapped avenues in the space, thus leading to revenue growth. The traditional methods of cloning and mutagenesis are quickly being substituted by de novo gene synthesis, which also allows nucleic acid production.
Data Bridge Market Research analyses that the gene synthesis software market is expected to reach USD 5.75 billion by 2030, which is USD 1.47 billion in 2022, and is expected to undergo a CAGR of 18.6% during the forecast period 2022 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Gene Synthesis Software Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Billion, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Application (Research and Development Activities, Diagnostics, Therapeutics, Others) End User (Academic and Research Institutes, Biotech and Pharmaceutical Companies, Diagnostic Laboratories, Others), Synthesis Type (Gene Library Synthesis, Custom Gene Synthesis), Method (Solid Phase Synthesis, Chip-Based DNA Synthesis, PCR-Based Enzyme Synthesis), End User (Hospitals, Trauma Centres, Ambulatory Surgical Centres and Other), Distribution Channel (Direct Tender and Retail Sales)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
GenScript (China), Sangamo Therapeutics (U.S.), Eurofins Genomics (Japan), ATDBio Ltd (U.K.), BIONEER CORPORATION. (South Korea), Kaneka Eurogentec S.A. (Belgium)., GENEWIZ Germany GmbH (Germany), Twist Bioscience (U.S.), Synthetic Genomics (U.S.), Codexis Inc. (U.S.), Synthego (U.S.), Creative Enzymes (U.S.), Eurofins Scientific (Luxembourg), Cyrus Biotechnology Inc. (U.S.), ATUM (U.S.), TeselaGen (U.S.), Arzeda (U.S.), Integrated DNA Technologies Inc. (U.S.), New England Biolabs (U.S.), Quintara Biosciences (U.S.), Genome Medical, Inc. (U.S.), BioMed Central Ltd (U.K.)
|
|
Market Opportunities
|
|
Market Definition
Gene synthesis is the process of generating artificial genes in a lab setting with the help of synthetic biology. The generation of recombinant proteins is one of the several applications of recombinant DNA technology, wherein the gene synthesis is developing as a major instrument
Gene Synthesis Software Market Dynamics
Drivers
- Increasing demand of solid-phase synthesis
The solid-phase synthesis came into much limelight in recent years. The high accuracy of this method boosts its disposition among therapy developers and research settings. Though, its high cost and low output hamper its usage in some cases, are creating much opportunities for other methods. PCR- and other chip-based methods are projected to show major CAGRs during the forecast period. These methods permit the synthesis of larger fragments at a much lower rate, leading to their increased usage. Additionally, the PCR-based method offers high accuracy of the gene sequence using cell systems.
- High use of personalized medicine
Growing demand for personalized medicines has led the way for genomics that demands the error-free gene sequences at a much low cost in a very short period, therefore acts as an opportunity for the gene synthesis market.
Opportunities
- Increased clinical research and technological advancement
The diverse advances in synthetic DNA technology are attracting much attraction as a feasible measure to address issues associated with the increasing number of developing pathogens and the threats of the next global pandemic. This strategy became helpful in responding quickly to the SARS-CoV-2 pandemic along with the near-future pandemics involving other novel pathogens.Thus, this boost the market growth. In the last few decades, targeted therapy is in much use by researchers as well as by biotechnology and pharmaceutical companies. It has developed as an important way of disease management. This therapy along with chemotherapy and immunotherapy is anticipated to witness major growth in the near future, which in turn, is creating much opportunities for the developing players in the market.
Restraints/Challenges
- Huge cost of diagnostic tests
Several tests are widely available for testing cardiovascular, chronic diseases, and other conditions such as diabetes. But these tests are of heavy cost which many patients can't afford, particularly those belonging to the lower economic groups. Therefore, it hampers the market growth.
- Lack of skilled professionals
A scarcity of skilled professionals in the field of gene synthesis and biotechnology is a major obstacle for the market growth, as the key market players require trained and experienced staff at their facilities. Therefore, several companies are now partnering with numerous universities and offering on-site training, online workshops, and sponsored projects to hugely develop the right professionals, thus boosting the market growth
This gene synthesis software market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the gene synthesis software market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Gene Synthesis Software Market
The COVID-19 pandemic has benefited the market, with respect to new growth opportunities. Several scientific communities are discovering untapped avenues in the space, thus leading to higher revenue growth. For instance, researchers at the National Institute of Standards and Technology (NIST) have developed synthetic gene fragments from the COVID-19 virus to help different diagnostic developers to launch more accurate and reliable diagnostic tests for the disease
Recent Developments
In 2020, Twist Bioscience launched clonal-ready gene fragments in order to complete the offering of genes. These fragments can be used with or without adapters to build up the perfect clones. The clonal-ready gene fragments are compatible with the enzyme engineering, and gene expression, protein expression pathways, among others.
Global Gene Synthesis Software Market Scope
The gene synthesis software market is segmented on the basis of applications, synthesis type, method, and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Application
- Research and Development Activities
- Diagnostics
- Therapeutics
- Others
Synthesis Type
- Gene Library Synthesis
- Custom Gene Synthesis
Method
- Solid Phase Synthesis
- Chip-Based DNA Synthesis
- PCR-Based Enzyme Synthesis
End-user
- Hospital and Clinics
- Diagnostic Laboratories
- Others
Gene Synthesis Software Regional Analysis/Insights
The gene synthesis software market is analyzed and market size insights and trends are provided by applications, synthesis type, method and end-user as referenced above.
The countries covered in the gene synthesis software market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the gene synthesis software market due to the growing demand from the academic institutes and biopharmaceutical companies with occurrence of numerous market players in the region.
Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030 due to the growing levels of investment for synthetic biology and the incidence of private companies in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The gene synthesis software market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for gene synthesis software market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the gene synthesis software market. The data is available for historic period 2011-2020.
Competitive Landscape and Global Gene Synthesis Software Market Share Analysis
The gene synthesis software market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to gene synthesis software market.
Some of the major players operating in the gene synthesis software market are:
- GenScript (China)
- Sangamo Therapeutics (U.S.)
- Eurofins Genomics (Japan)
- ATDBio Ltd (U.S.)
- BIONEER CORPORATION. (South Korea)
- Kaneka Eurogentec S.A. (Belgium)
- GENEWIZ Germany GmbH (Germany)
- Twist Bioscience (U.S.)
- Synthetic Genomics (U.S.)
- Codexis Inc. (U.S.)
- Synthego (U.S.)
- Creative Enzymes (U.S.)
- Eurofins Scientific (Luxembourg)
- Cyrus Biotechnology Inc. (U.S.)
- ATUM (U.S.)
- TeselaGen (U.S.)
- Arzeda (U.S.)
- Integrated DNA Technologies Inc. (U.S.)
- New England Biolabs (U.S.)
- Genome Medical, Inc. (U.S.)
- BioMed Central Ltd (U.K.)
SKU-